Arzu Akcay
Overview
Explore the profile of Arzu Akcay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Atay D, Akcay A, Akinci B, Demir Yenigurbuz F, Ovali E, Ozturk G
Pediatr Transplant
. 2021 Aug;
25(8):e14120.
PMID: 34409718
Background: Haploidentical HSCT is a good option for children with PIDs lacking an HLA-matched donor. Co-transplantation of MSCs during haploidentical HSCT in patients with PIDs may enhance engraftment, decrease the...
12.
Atay D, Akcay A, Demir Yenigurbuz F, Akinci B, Bagirova K, Hasanova S, et al.
Pediatr Transplant
. 2021 Jul;
25(8):e14098.
PMID: 34313359
Background: Anti-human T-lymphocyte immunoglobulin is commonly used as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors. The studies according to optimum dose of ATLG especially...
13.
Akcay A, Atay D, Erbey F, Akinci B, Demir Yenigurbuz F, Eyuboglu F, et al.
Exp Clin Transplant
. 2021 Jun;
20(12):1114-1121.
PMID: 34142939
Objectives: The mostimportant problems thatlimitthe effectiveness of allogeneic hematopoietic stem cell transplantation in patients with severe aplastic anemia are graft failure and graft-versus-host disease. Mesenchymal stem cells can support normal...
14.
Akkoc Y, Peker N, Akcay A, Gozuacik D
Front Oncol
. 2021 Apr;
11:627023.
PMID: 33816262
Metastasis and relapse account for the great majority of cancer-related deaths. Most metastatic lesions are micro metastases that have the capacity to remain in a non-dividing state called "dormancy" for...
15.
Arslan M, Buyuk Y, Ziyade N, Elgormus N, Sirin G, Coban I, et al.
Ir J Med Sci
. 2021 Mar;
191(2):529-541.
PMID: 33755916
Background/aims: The aim of this study is to share autopsy findings of COVID-19-positive cases and autopsy algorithms for safely handling of suspicious bodies during this pandemic. Methods: COVID-19-positive cases of...
16.
Kayaoglu B, Kasap N, Surucu Yilmaz N, Charbonnier L, Geckin B, Akcay A, et al.
J Clin Immunol
. 2021 Jan;
41(4):769-779.
PMID: 33475942
Purpose: Patients with heterozygous gain-of-function (GOF) mutations in STAT1 frequently exhibit chronic mucocutaneous candidiasis (CMC), immunodeficiency and autoimmune manifestations. Several treatment options including targeted therapies and hematopoietic stem cell transplantation...
17.
Hazar V, Karasu G, Ozturk G, Kupesiz A, Aksoylar S, Ozbek N, et al.
Pediatr Transplant
. 2020 Dec;
25(5):e13942.
PMID: 33320995
Background: Post-transplant relapse has a dismal prognosis in children with acute leukemia undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Data on risk factors, treatment options, and outcomes are limited. Procedure:...
18.
Beken S, Sariyilmaz K, Albayrak E, Akcay A, Korkmaz A
Turk J Haematol
. 2020 Oct;
38(3):222-223.
PMID: 33053965
No abstract available.
19.
Akcay A, Atay D, Yilanci M, Kongur M, Eyuboglu F, Ozturk G, et al.
J Pediatr Hematol Oncol
. 2020 Oct;
43(3):e312-e319.
PMID: 33031163
Mesenchymal stem cells (MSCs) have been used systemically or locally in many chronic and nonhealing skin lesions in recent years. In this study, umbilical cord-derived MSCs (UC-MSCs)-seeded fibrin matrix was...
20.
Hazar V, Karasu G, Uygun V, Ozbek N, Karakukcu M, Ozturk G, et al.
Leuk Lymphoma
. 2020 Feb;
61(6):1465-1474.
PMID: 32037917
We examined outcomes of 51 pediatric patients with relapsed acute leukemia (AL) who underwent a second allogeneic hematopoietic stem cell transplantation (alloHSCT). After a median follow-up of 941 days (range,...